Matches 1 - 50 out of 95 1 2 >


Match Document Document Title
US20120087860 METHODS FOR IN VIVO CANCER DETECTION, DIAGNOSIS AND THERAPY USING MULTIDOMAIN BIOTAGS  
In another embodiment, a method for detecting and/or diagnosing a cancer in a subject is provided. The method may include administering an effective dose of a biotag to a subject, or...
US20130129632 Quantum dot materials, methods for making them, and uses thereof  
The disclosure provides quantum dot materials, compositions and methods useful in the treatment of various disorders. In particular, the disclosure provides cadmium-free and lead-free quantum dots.
US20140343413 FORMULATION OF SOLID NANO-SIZED PARTICLES IN A GEL-FORMING SYSTEM  
The present invention relates to novel formulations comprising a plurality of nano-sized solid particles and a gel-forming system, useful, e.g. for imaging of the body of a mammal. Also described...
US20110097276 Diagnosis of Prostate Cancer  
Methods for diagnosing prostate cancer, and differentiate prostate cancer from other prostate complications, and use of said method, and diagnosing and monitoring lymph gland metastasis, post...
US20130089505 SINGLE VIAL FORMULATION FOR MEDICAL GRADE CYANOACRYLATE  
Alkyl cyanoacrylate compositions and methods for making those compositions, utilizing high purity monomeric starting materials, formed into more viscous oligomers, and combined with a plasticizer...
US20130030282 SYNTHESIS AND CHARACTERIZATION OF NEAR IR FLUORESCENT MAGNETIC AND NON-MAGNETIC ALBUMIN NANOPARTICLES FOR BIOMEDICAL APPLICATIONS  
The present invention discloses Near Infrared (NIR) fluorescent albumin nanoparticles having a structure selected from a core structure or a core-shell structure. Also disclosed are a process of...
US20150173847 IMAGING MARKER AND UTILIZATION THEREOF  
As an imaging marker for generating suitable contrasts in images taken through a plurality of medical diagnostic imaging techniques, a liquid containing a transition metal belonging to any of the...
US20110020243 METHODS AND COMPOSITIONS FOR IMAGING CANCER CELLS  
Disclosed are compositions comprising nanoparticles and uses thereof. Such nanoparticles include gold nanoparticles conjugated to glucose or a glucose derivative, which are useful as contrast...
US20130045161 METHODS AND COMPOSITIONS FOR TARGETED IMAGING  
A new approach to targeting imaging agents to macrophage-rich sites of interest is disclosed. Compositions of the invention are rHDL and HDL-like liposomal compositions, protein constituents of...
US20110117027 INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION  
The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present...
US20110044897 METHOD OF IMAGING LOCALIZED INFECTIONS  
The invention relates to a method for targeting an imaging agent to cells of an animal to detect localized infections. More particularly, localized infections are detected by targeting imaging...
US20120004531 Innately Multimodal Nanoparticles  
A gold-coated iron oxide nanoparticle, method of making thereof, and method of using thereof is disclosed. The nanoparticle is substantially toxin free (making it clinically applicable), easily...
US20120282185 PARTICLES FOR THE TREATMENT OF CANCER IN COMBINATION WITH RADIOTHERAPY  
The invention provides a particle comprising a metal oxide which is doped with at least one rare earth element, wherein the metal oxide is selected from titanium dioxide, zinc oxide, cerium oxide...
US20130052142 LOADABLE POLYMERIC PARTICLES FOR THERAPEUTIC AND/OR DIAGNOSTIC APPLICATIONS AND METHODS OF PREPARING AND USING THE SAME  
Particles are provided for use in therapeutic and/or diagnostic procedures. The particles include poly[bis(trifluoroethoxy)phosphazene] and/or a derivatives thereof which may be present throughout...
US20100329991 Medicinal preparation particularly for the treatment of slipped discs hernias  
The invention concerns a product consisting in an injection medicinal formulations comprising at least one compound to provide a viscous formulation, ethanol and at least one compound making said...
US20100310474 PROTEIN CAGES FOR THE DELIVERY OF MEDICAL IMAGING AND THERAPEUTIC AGENTS  
The present invention is directed to novel compositions and methods utilizing delivery agents comprising protein cages, medical imaging agents and therapeutic agents.
US20130084248 STABILIZED, BIOCOMPATIBLE GOLD NANOPARTICLES  
The invention provides stabilized, biocompatible gold nanoparticles that are stabilized with material from polyphenols- or flavanoids-rich plant material or reactive phytochemical components of...
US20080241072 INJECTABLE VOID FILLER FOR SOFT TISSUE AUGMENTATION  
The present invention teaches a micro-porous injectable, soft elastic, fully resorbable fibrin-based composition for use as a soft tissue lumen and void filler. The composition of the present...
US20120087868 NANOPARTICLE-LOADED CELLS  
The invention provides nanoparticle-loaded cells and compositions useful for improved imaging and therapy, for example radio-therapy. The invention also provides methods of manufacture of...
US20120156132 TARGETING AGENT TO NEWLY FORMED BLOOD VESSELS  
It is an object of the present invention to provide a targeting agent that enables drug delivery to a neovascular site and the imaging of such a neovascular site, utilizing the effect of the agent...
US20120258051 Multistrata nanoparticles and methods for making multistrata nanoparticles  
A composition comprising a core comprising an iron oxide, a first shell comprising at least one plasmon active metal at least partially surrounding the core, a second shell comprising a dielectric...
US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine  
Disclosed is the surprising discovery that aminophospholipids, such as phosphatidylserine and phosphatidylethanolamine, are specific, accessible and stable markers of the luminal surface of tumor...
US20150037250 CONTRAST AGENT  
According to one embodiment, a contrast agent includes a blood vessel contrast enhancement particles configured to enhance contrast of a blood vessel of an object and a diseased tissue contrast...
US20110064676 Diagnostic and therapeutic nanoparticles  
The present invention relates to diagnostic and therapeutic nanoparticles. More particularly, the present invention relates to creating a hybrid gold/gold sulfide nanoparticle with a chitosan...
US20110311456 MARKER ALLOY  
A marker alloy foreign implant made of a biodegradable metallic material and having the composition MgxYbyMz wherein x is equal to 10-60 atomic percent; y is equal to 40-90 atomic percent; z is...
US20100297019 PARTICLES FOR IMAGING  
The invention encompasses particles comprising metal atoms, methods of making the particles, and methods for using the particles. In particular, the particles may be used to image biological...
US20150139913 MEDICAL USE OF PARTICLES OF TITANIUM AND/OR TITANIUM OXIDE  
The present invention describes particles of titanium, titanium alloy, at least one type of titanium oxide or a combination thereof, wherein at least a substantial amount of the particles are of...
US20120148501 RADIOLOGICAL IMAGE ENHANCEMENT WITH TANTALUM CLUSTERS  
A solution comprising a defined concentration of purified tantalum clusters in a solvent selected from the group consisting of water, ethanol, ethylene glycol and propylene glycol; wherein said...
US20150122695 ASSOCIATION OF POLY(N-ACRYLOYLGLYCINAMIDE) WITH AT LEAST ONE ACTIVE PRINCIPLE  
The present invention relates to an association of poly (N-acryloyl glycinamide) with at least one active principle and/or at least one product which is visible in medical imaging, in a...
US20120052006 GOLD/LANTHANIDE NANOPARTICLE CONJUGATES AND USES THEREOF  
The present disclosure is directed generally to gold/lanthanide nanoparticle conjugates, such as gold/gadolinium nanoparticle conjugates, nanoparticle conjugates including polymers, nanoparticle...
US20060034768 Method and device for molecular imaging with the aid of molecular probe  
A method is disclosed for molecular imaging with the aid of a molecular probe, the latter containing a contrast enhancing component that is detectable via X-ray fluorescence radiation emitted...
US20140227194 Preparation for Restenosis Prevention  
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected...
US20140227193 Preparation for Restenosis Prevention  
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected...
US20140227192 Preparation for Restenosis Prevention  
The invention relates to a preparation for restenosis prevention. The preparations for restenosis prevention known as yet do not reach sufficient active agent concentrations in the affected...
US20110165075 INTEGRIN TARGETING AGENTS AND IN-VIVO AND IN-VITRO IMAGING METHODS USING THE SAME  
The invention provides a family of agents that target integrins, which can be used as imaging agents and/or therapeutic agents. The agents can be used to image angiogenesis, inflammation or other...
US20140249391 TISSUE VISUALIZATION FOR RESECTION  
Methods for distinguishing between two interspersed biological tissues, for procedures such as surgical resection, include exposing the tissues to at least two components, a first of which...
US20050008574 Use of intravenous contrast media for projection mammography  
The invention relates to the use of intravenous contrast media for projection mammography as well as new devices for projection mammography. The invention therefore relates to the use of...
US20100047181 MIXTURE OF A VANILLOID RECEPTOR AGONIST AND A SUBSTANCE INHIBITING NERVE REGENERATION, USE THEREOF FOR PRODUCING A PAINKILLER, AND METHOD FOR APPLYING SAID PAINKILLER  
The following abstract will replace all prior versions of the abstract in the application: The mixture comprises a vanilloid receptor agonist with a substance, which inhibits nerve regeneration....
US20080003183 Nanoparticle radiosensitizers  
Herein is described Nanostructure Enhanced X-ray Therapy (NEXT), which uses nanomaterials as radiosensitizers to enhance electromagnetic radiation absorption in specific cells or tissues. The...
US20150004103 Tumorspecific PET/MR(T1), PET/MR(T2) and PET/CT contrast agent  
New types of nanoparticle-based dual-modality positron emission tomography/magnetic resonance imaging (PET/MRI) and positron emission tomography/computed tomography (PET/CT) tumorspecific contrast...
US20130017155 DUAL CT/MRI NANOPARTICLE CONTRAST AGENT  
The invention relates to a new tungsten-iron-Ferritin nanoparticle and uses thereof in imaging.
US20070116647 Medicinal preparation particularly for the treatment of slipped discs hernias  
The invention concerns a product consisting in an injection medicinal formulations comprising at least one compound to provide a viscous formulation, ethanol and at least one compound making said...
US20090074674 Stabilized, biocompatible gold nanoparticles and enviro-friendly method for making same  
The invention provides stabilized, biocompatible gold nanoparticles that are stabilized with material from polyphenols- or flavanoids-rich plant material or reactive phytochemical components of...
US20070217996 Activatable Particles, Preparations and Uses  
The present invention relates to novel activatable particles which can be used in the health sector. The invention more particularly relates to composite particles which can generate free radicals...
US20130065995 Surface-Modified Tantalum Oxide Nanoparticles, Preparation Method Thereof, and Contrast Medium for X-Ray Computed Tomography and Highly Dielectric Thin Film Using Same  
The present invention relates to a surface-modified tantalum oxide nanoparticle, a method for preparation thereof, a contrast agent (medium) for X-ray computed tomography, and a highly dielectric...
US20110104072 TREATING WATER INSOLUBLE NANOPARTICLES WITH HYDROPHILIC ALPHA-HYDROXYPHOSPHONIC ACID CONJUGATES, THE SO MODIFIED NANOPARTICLES AND THEIR USE AS CONTRAST AGENTS  
The present application discloses treating water insoluble nanoparticles, particularly nanoparticles of metals and metal compounds which find utility in diagnostic imaging such as MR and X-ray...
US20120128583 DTPA DERIVATIVE, METAL COMPLEX, MR AND CT CONTRAST AGENT AND METHOD FOR MANUFACTURING SAME  
The present invention relates to DTPA derivatives capable of forming complexes by combining with metals and the like, metal complexes formed by combining with the DTPA derivatives, MR and CT...
US20090191121 Targeting and Imaging Tumor Vasculature Using Conjugates That Bind to Aminophospholipids  
Disclosed is the surprising discovery that aminophospholipids, such as phosphatidyserine and phosphatidylethanolamine, are specific, accessible and stable markers of the luminal surface of tumor...
US20130142729 Anti-CD74 Immunoconjugates and Methods of Use  
Disclosed are compositions that include anti-CD74 immunoconjugates and optionally a therapeutic and/or diagnostic agent. In preferred embodiments, the immunoconjugates comprise one or more...
US20100284936 CONTRAST AGENTS  
The present invention relates to liposomes comprising particles with cores of tungsten or tungsten in mixture with other metallic elements as the contrast enhancing material and to the use of such...

Matches 1 - 50 out of 95 1 2 >